Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bipolar Disorder | 87 | 2024 | 5077 | 9.380 |
Why?
|
Cognition Disorders | 41 | 2024 | 3976 | 4.280 |
Why?
|
Cognition | 57 | 2024 | 6948 | 2.790 |
Why?
|
Neuropsychological Tests | 56 | 2024 | 7016 | 2.480 |
Why?
|
Schizophrenia | 52 | 2023 | 6915 | 2.310 |
Why?
|
Schizophrenic Psychology | 23 | 2019 | 1646 | 1.850 |
Why?
|
Nootropic Agents | 5 | 2021 | 157 | 1.290 |
Why?
|
Social Behavior | 4 | 2019 | 1130 | 1.210 |
Why?
|
Depressive Disorder, Major | 8 | 2024 | 4735 | 0.990 |
Why?
|
Dopamine Agonists | 4 | 2021 | 352 | 0.890 |
Why?
|
Endophenotypes | 3 | 2013 | 255 | 0.840 |
Why?
|
Psychotic Disorders | 13 | 2022 | 3175 | 0.790 |
Why?
|
Lithium | 3 | 2023 | 596 | 0.780 |
Why?
|
Siblings | 3 | 2017 | 825 | 0.740 |
Why?
|
Social Perception | 2 | 2014 | 431 | 0.710 |
Why?
|
Personal Satisfaction | 1 | 2024 | 643 | 0.680 |
Why?
|
Impulsive Behavior | 5 | 2019 | 346 | 0.680 |
Why?
|
Affect | 6 | 2022 | 1479 | 0.670 |
Why?
|
Cyclothymic Disorder | 2 | 2020 | 42 | 0.650 |
Why?
|
Human Activities | 1 | 2019 | 26 | 0.650 |
Why?
|
Affective Symptoms | 2 | 2019 | 416 | 0.650 |
Why?
|
Intelligence | 5 | 2018 | 919 | 0.650 |
Why?
|
Emotions | 8 | 2023 | 2730 | 0.610 |
Why?
|
Decision Making | 10 | 2019 | 3924 | 0.610 |
Why?
|
Verbal Learning | 3 | 2017 | 462 | 0.590 |
Why?
|
Adult | 85 | 2024 | 219847 | 0.520 |
Why?
|
Sensation | 1 | 2017 | 331 | 0.510 |
Why?
|
Memory, Short-Term | 6 | 2022 | 977 | 0.510 |
Why?
|
Morals | 1 | 2018 | 289 | 0.510 |
Why?
|
Mood Disorders | 6 | 2022 | 1123 | 0.510 |
Why?
|
Humans | 156 | 2024 | 760261 | 0.500 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2018 | 284 | 0.490 |
Why?
|
Antipsychotic Agents | 8 | 2023 | 3061 | 0.440 |
Why?
|
Awareness | 1 | 2017 | 644 | 0.430 |
Why?
|
Catechol O-Methyltransferase | 3 | 2017 | 251 | 0.430 |
Why?
|
Carrier Proteins | 6 | 2010 | 4938 | 0.430 |
Why?
|
Psychotropic Drugs | 3 | 2014 | 882 | 0.430 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3822 | 0.420 |
Why?
|
Clinical Trials as Topic | 4 | 2018 | 8058 | 0.410 |
Why?
|
Middle Aged | 61 | 2024 | 220175 | 0.410 |
Why?
|
Male | 91 | 2024 | 359413 | 0.390 |
Why?
|
Genotype | 13 | 2013 | 12959 | 0.390 |
Why?
|
Nerve Fibers, Myelinated | 6 | 2013 | 952 | 0.390 |
Why?
|
Memory Disorders | 2 | 2017 | 1197 | 0.380 |
Why?
|
Benzothiazoles | 2 | 2011 | 246 | 0.380 |
Why?
|
Polymorphism, Single Nucleotide | 21 | 2019 | 15766 | 0.370 |
Why?
|
Female | 91 | 2024 | 391011 | 0.370 |
Why?
|
Depression | 8 | 2024 | 8033 | 0.360 |
Why?
|
Cluster Analysis | 4 | 2020 | 2698 | 0.360 |
Why?
|
Nerve Tissue Proteins | 6 | 2011 | 4409 | 0.360 |
Why?
|
Oxytocin | 1 | 2014 | 401 | 0.350 |
Why?
|
Genetic Predisposition to Disease | 23 | 2023 | 17766 | 0.350 |
Why?
|
Pharmacogenetics | 3 | 2023 | 680 | 0.340 |
Why?
|
Suicide, Attempted | 3 | 2019 | 1387 | 0.340 |
Why?
|
Antidepressive Agents | 4 | 2023 | 2889 | 0.340 |
Why?
|
Psychiatric Status Rating Scales | 18 | 2022 | 6017 | 0.330 |
Why?
|
Dopamine | 3 | 2017 | 1583 | 0.330 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 8 | 2018 | 1988 | 0.320 |
Why?
|
Social Adjustment | 2 | 2010 | 632 | 0.320 |
Why?
|
Receptors, Growth Factor | 1 | 2010 | 326 | 0.320 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 25928 | 0.310 |
Why?
|
Psychomotor Disorders | 1 | 2009 | 149 | 0.310 |
Why?
|
Anxiety Disorders | 1 | 2019 | 2711 | 0.310 |
Why?
|
Risk-Taking | 2 | 2013 | 1000 | 0.310 |
Why?
|
Anorexia Nervosa | 1 | 2017 | 1361 | 0.300 |
Why?
|
Attention | 6 | 2017 | 2386 | 0.290 |
Why?
|
Obsessive-Compulsive Disorder | 3 | 2018 | 1488 | 0.290 |
Why?
|
Sleep Apnea Syndromes | 1 | 2015 | 973 | 0.280 |
Why?
|
Brain | 13 | 2022 | 26912 | 0.270 |
Why?
|
Executive Function | 7 | 2019 | 1370 | 0.270 |
Why?
|
Genetic Variation | 6 | 2017 | 6540 | 0.270 |
Why?
|
Genome-Wide Association Study | 15 | 2023 | 12602 | 0.260 |
Why?
|
Haplotypes | 10 | 2011 | 2764 | 0.260 |
Why?
|
Epistasis, Genetic | 1 | 2008 | 350 | 0.260 |
Why?
|
Reaction Time | 5 | 2021 | 2075 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2010 | 567 | 0.260 |
Why?
|
Institutionalization | 1 | 2005 | 105 | 0.250 |
Why?
|
Educational Status | 2 | 2019 | 2512 | 0.250 |
Why?
|
Adaptation, Psychological | 1 | 2016 | 2628 | 0.250 |
Why?
|
Psychomotor Performance | 3 | 2010 | 1876 | 0.240 |
Why?
|
Child Abuse | 1 | 2013 | 1068 | 0.230 |
Why?
|
Ketamine | 2 | 2024 | 516 | 0.230 |
Why?
|
Aged | 29 | 2024 | 168995 | 0.230 |
Why?
|
Young Adult | 23 | 2022 | 58673 | 0.230 |
Why?
|
Circadian Rhythm | 1 | 2015 | 2567 | 0.230 |
Why?
|
Case-Control Studies | 16 | 2020 | 22041 | 0.220 |
Why?
|
Facial Expression | 3 | 2023 | 509 | 0.220 |
Why?
|
Psychometrics | 7 | 2017 | 3049 | 0.220 |
Why?
|
Self-Assessment | 1 | 2005 | 393 | 0.210 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2021 | 598 | 0.210 |
Why?
|
Microtubule-Associated Proteins | 1 | 2008 | 1078 | 0.210 |
Why?
|
Focal Adhesions | 1 | 2023 | 115 | 0.210 |
Why?
|
Quality of Life | 2 | 2021 | 13300 | 0.200 |
Why?
|
Dystrophin-Associated Proteins | 5 | 2010 | 59 | 0.200 |
Why?
|
Phenotype | 6 | 2010 | 16543 | 0.200 |
Why?
|
Marijuana Abuse | 3 | 2012 | 411 | 0.190 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2019 | 4547 | 0.190 |
Why?
|
Mastocytosis | 1 | 2024 | 149 | 0.190 |
Why?
|
Adolescent | 26 | 2022 | 87747 | 0.190 |
Why?
|
Temperament | 2 | 2014 | 295 | 0.190 |
Why?
|
Receptors, Dopamine | 2 | 2013 | 292 | 0.190 |
Why?
|
Consensus | 5 | 2019 | 3106 | 0.190 |
Why?
|
Piracetam | 1 | 2002 | 88 | 0.190 |
Why?
|
Research Design | 4 | 2017 | 6181 | 0.180 |
Why?
|
Double-Blind Method | 7 | 2021 | 12412 | 0.180 |
Why?
|
Neurogenesis | 2 | 2020 | 855 | 0.170 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2001 | 140 | 0.170 |
Why?
|
Mental Disorders | 4 | 2020 | 6797 | 0.170 |
Why?
|
Smoking | 1 | 2016 | 9070 | 0.170 |
Why?
|
Brain Mapping | 6 | 2018 | 6562 | 0.170 |
Why?
|
Lithium Compounds | 2 | 2023 | 225 | 0.170 |
Why?
|
Analysis of Variance | 5 | 2013 | 6242 | 0.160 |
Why?
|
Amines | 1 | 2001 | 281 | 0.160 |
Why?
|
Severity of Illness Index | 12 | 2020 | 15827 | 0.160 |
Why?
|
Genomics | 2 | 2023 | 5790 | 0.160 |
Why?
|
Longitudinal Studies | 6 | 2022 | 14482 | 0.150 |
Why?
|
Nervous System Diseases | 1 | 2009 | 1647 | 0.150 |
Why?
|
Serotonin Antagonists | 1 | 2018 | 144 | 0.150 |
Why?
|
Frontal Lobe | 4 | 2019 | 1422 | 0.150 |
Why?
|
Ondansetron | 1 | 2018 | 95 | 0.150 |
Why?
|
Anticonvulsants | 3 | 2023 | 1881 | 0.150 |
Why?
|
Cerebral Cortex | 5 | 2018 | 5755 | 0.150 |
Why?
|
Multifactorial Inheritance | 4 | 2018 | 1351 | 0.150 |
Why?
|
Touch Perception | 1 | 2018 | 106 | 0.140 |
Why?
|
Statistics as Topic | 4 | 2017 | 2363 | 0.140 |
Why?
|
Substance-Related Disorders | 1 | 2013 | 4370 | 0.140 |
Why?
|
DNA Copy Number Variations | 2 | 2018 | 2008 | 0.140 |
Why?
|
Mental Health | 2 | 2022 | 3206 | 0.140 |
Why?
|
Aminopyridines | 1 | 2020 | 564 | 0.140 |
Why?
|
Self Report | 2 | 2018 | 3707 | 0.140 |
Why?
|
Intra-Abdominal Fat | 1 | 2021 | 607 | 0.130 |
Why?
|
Thalamus | 4 | 2013 | 1041 | 0.130 |
Why?
|
Demography | 2 | 2019 | 1650 | 0.130 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2008 | 375 | 0.130 |
Why?
|
Prefrontal Cortex | 4 | 2018 | 2212 | 0.130 |
Why?
|
Individuality | 1 | 2017 | 300 | 0.130 |
Why?
|
Aging | 5 | 2024 | 8641 | 0.130 |
Why?
|
Receptors, Immunologic | 1 | 2022 | 1434 | 0.130 |
Why?
|
Bulimia Nervosa | 1 | 2017 | 206 | 0.130 |
Why?
|
Alleles | 7 | 2023 | 6900 | 0.120 |
Why?
|
Central Nervous System Stimulants | 1 | 2024 | 1169 | 0.120 |
Why?
|
Regression Analysis | 4 | 2020 | 6361 | 0.120 |
Why?
|
Factor Analysis, Statistical | 1 | 2017 | 998 | 0.120 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2001 | 1132 | 0.120 |
Why?
|
Piperazines | 2 | 2020 | 2520 | 0.120 |
Why?
|
Gene Regulatory Networks | 1 | 2023 | 1740 | 0.120 |
Why?
|
Aggression | 1 | 2019 | 745 | 0.110 |
Why?
|
Games, Experimental | 1 | 2013 | 32 | 0.110 |
Why?
|
Longevity | 1 | 2021 | 1050 | 0.110 |
Why?
|
Ankyrins | 1 | 2013 | 123 | 0.110 |
Why?
|
Risperidone | 3 | 2015 | 379 | 0.110 |
Why?
|
Autistic Disorder | 1 | 2023 | 1213 | 0.110 |
Why?
|
Anisotropy | 5 | 2019 | 1278 | 0.110 |
Why?
|
International Classification of Diseases | 1 | 2018 | 884 | 0.110 |
Why?
|
Synaptic Transmission | 1 | 2019 | 1169 | 0.110 |
Why?
|
Irritable Mood | 1 | 2014 | 194 | 0.110 |
Why?
|
Developing Countries | 1 | 2005 | 2880 | 0.110 |
Why?
|
Disability Evaluation | 3 | 2016 | 1826 | 0.100 |
Why?
|
Calcium Channels, L-Type | 1 | 2013 | 240 | 0.100 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2024 | 3695 | 0.100 |
Why?
|
Cerebrum | 1 | 2013 | 132 | 0.100 |
Why?
|
Intelligence Tests | 2 | 2012 | 498 | 0.100 |
Why?
|
Excitatory Amino Acid Agents | 1 | 2011 | 23 | 0.100 |
Why?
|
Reward | 2 | 2019 | 964 | 0.090 |
Why?
|
Cohort Studies | 9 | 2022 | 41317 | 0.090 |
Why?
|
Child | 11 | 2020 | 79758 | 0.090 |
Why?
|
Suicidal Ideation | 1 | 2020 | 1435 | 0.090 |
Why?
|
Linear Models | 2 | 2019 | 5876 | 0.090 |
Why?
|
Treatment Outcome | 8 | 2021 | 64947 | 0.090 |
Why?
|
Receptors, Glutamate | 1 | 2011 | 229 | 0.090 |
Why?
|
Survivors | 1 | 2021 | 2367 | 0.090 |
Why?
|
Chicago | 1 | 2010 | 244 | 0.090 |
Why?
|
Dopamine Agents | 1 | 2011 | 189 | 0.090 |
Why?
|
Homozygote | 3 | 2015 | 1786 | 0.090 |
Why?
|
Outpatients | 2 | 2016 | 1606 | 0.090 |
Why?
|
Diffusion Magnetic Resonance Imaging | 4 | 2014 | 2776 | 0.090 |
Why?
|
Corpus Callosum | 1 | 2014 | 749 | 0.090 |
Why?
|
Wechsler Scales | 2 | 2008 | 257 | 0.080 |
Why?
|
Antimanic Agents | 2 | 2023 | 520 | 0.080 |
Why?
|
Disease Progression | 2 | 2022 | 13505 | 0.080 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2010 | 311 | 0.080 |
Why?
|
Marijuana Smoking | 1 | 2012 | 257 | 0.080 |
Why?
|
Gambling | 3 | 2007 | 258 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2578 | 0.080 |
Why?
|
Neurodegenerative Diseases | 1 | 2018 | 1083 | 0.080 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2011 | 415 | 0.080 |
Why?
|
Origin Recognition Complex | 1 | 2008 | 20 | 0.080 |
Why?
|
Genetic Markers | 4 | 2009 | 2608 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 4357 | 0.080 |
Why?
|
Risk Factors | 11 | 2020 | 74269 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1395 | 0.080 |
Why?
|
Personality Inventory | 1 | 2011 | 1018 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 12 | 2022 | 36247 | 0.080 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2008 | 127 | 0.080 |
Why?
|
Advisory Committees | 3 | 2019 | 789 | 0.070 |
Why?
|
Thiazoles | 2 | 2006 | 1509 | 0.070 |
Why?
|
Genetic Loci | 4 | 2018 | 2618 | 0.070 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2010 | 503 | 0.070 |
Why?
|
Valine | 1 | 2009 | 409 | 0.070 |
Why?
|
Gene Frequency | 3 | 2017 | 3605 | 0.070 |
Why?
|
Binding, Competitive | 1 | 2008 | 1143 | 0.070 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2008 | 452 | 0.070 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2006 | 109 | 0.070 |
Why?
|
Valproic Acid | 2 | 2016 | 442 | 0.070 |
Why?
|
Penetrance | 1 | 2007 | 388 | 0.070 |
Why?
|
Polymorphism, Genetic | 3 | 2017 | 4286 | 0.060 |
Why?
|
Benzodiazepines | 2 | 2008 | 1132 | 0.060 |
Why?
|
Basal Ganglia | 1 | 2008 | 552 | 0.060 |
Why?
|
Inflammation | 2 | 2022 | 10757 | 0.060 |
Why?
|
Genes, Recessive | 1 | 2007 | 626 | 0.060 |
Why?
|
Mental Status Schedule | 1 | 2005 | 314 | 0.060 |
Why?
|
Temporal Lobe | 1 | 2012 | 1687 | 0.060 |
Why?
|
Age Factors | 5 | 2020 | 18415 | 0.060 |
Why?
|
Psychological Tests | 1 | 2007 | 639 | 0.060 |
Why?
|
Sleep | 1 | 2020 | 4746 | 0.060 |
Why?
|
Sex Factors | 3 | 2013 | 10530 | 0.060 |
Why?
|
Remission Induction | 2 | 2024 | 2394 | 0.060 |
Why?
|
Prospective Studies | 3 | 2022 | 54263 | 0.060 |
Why?
|
Delusions | 1 | 2006 | 298 | 0.060 |
Why?
|
Linkage Disequilibrium | 2 | 2008 | 1996 | 0.060 |
Why?
|
Reference Values | 2 | 2008 | 4920 | 0.060 |
Why?
|
Employment | 1 | 2010 | 1111 | 0.060 |
Why?
|
Comorbidity | 3 | 2022 | 10552 | 0.060 |
Why?
|
Hallucinations | 1 | 2006 | 366 | 0.060 |
Why?
|
Prevalence | 1 | 2020 | 15687 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2011 | 6499 | 0.050 |
Why?
|
DNA Replication | 1 | 2010 | 1412 | 0.050 |
Why?
|
Cross-Cultural Comparison | 1 | 2005 | 632 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2020 | 20048 | 0.050 |
Why?
|
Off-Label Use | 1 | 2024 | 184 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39254 | 0.050 |
Why?
|
Child Development | 1 | 2013 | 2280 | 0.050 |
Why?
|
Cerebellum | 1 | 2009 | 1495 | 0.050 |
Why?
|
Brazil | 1 | 2005 | 1214 | 0.050 |
Why?
|
Motivation | 1 | 2011 | 1990 | 0.050 |
Why?
|
Follicular Phase | 1 | 2021 | 143 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7468 | 0.050 |
Why?
|
Meta-Analysis as Topic | 3 | 2010 | 1375 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2895 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10761 | 0.050 |
Why?
|
Nerve Net | 2 | 2013 | 2258 | 0.050 |
Why?
|
Perimenopause | 1 | 2021 | 141 | 0.050 |
Why?
|
Diffusion Tensor Imaging | 3 | 2019 | 2383 | 0.040 |
Why?
|
Carbamazepine | 1 | 2001 | 224 | 0.040 |
Why?
|
Methylphenidate | 1 | 2024 | 483 | 0.040 |
Why?
|
Taiwan | 1 | 2020 | 503 | 0.040 |
Why?
|
Australia | 1 | 2023 | 1288 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2018 | 80301 | 0.040 |
Why?
|
Neural Pathways | 4 | 2012 | 3039 | 0.040 |
Why?
|
Acetates | 1 | 2001 | 322 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12915 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 2024 | 2235 | 0.040 |
Why?
|
Recurrence | 1 | 2011 | 8487 | 0.040 |
Why?
|
Triazines | 1 | 2001 | 310 | 0.040 |
Why?
|
Fructose | 1 | 2001 | 287 | 0.040 |
Why?
|
Risk | 2 | 2013 | 9629 | 0.040 |
Why?
|
Personality | 1 | 2022 | 552 | 0.040 |
Why?
|
Early Diagnosis | 2 | 2017 | 1181 | 0.040 |
Why?
|
Cefotaxime | 1 | 2017 | 35 | 0.040 |
Why?
|
Societies, Medical | 1 | 2010 | 3903 | 0.040 |
Why?
|
Algorithms | 2 | 2017 | 13967 | 0.040 |
Why?
|
Internal Capsule | 1 | 2019 | 138 | 0.040 |
Why?
|
Depressive Disorder | 1 | 2010 | 3728 | 0.040 |
Why?
|
Ambulatory Care | 2 | 2006 | 2783 | 0.040 |
Why?
|
Gene Duplication | 1 | 2018 | 314 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2004 | 4900 | 0.040 |
Why?
|
Sleep, REM | 1 | 2020 | 593 | 0.040 |
Why?
|
Cognitive Reserve | 1 | 2018 | 92 | 0.040 |
Why?
|
Developmental Disabilities | 1 | 2005 | 1504 | 0.030 |
Why?
|
Psychopathology | 1 | 2019 | 427 | 0.030 |
Why?
|
Age of Onset | 3 | 2007 | 3302 | 0.030 |
Why?
|
Genetic Association Studies | 2 | 2017 | 2716 | 0.030 |
Why?
|
Predictive Value of Tests | 4 | 2013 | 15273 | 0.030 |
Why?
|
Somatosensory Cortex | 1 | 2018 | 511 | 0.030 |
Why?
|
Cell Line | 1 | 2008 | 15626 | 0.030 |
Why?
|
Organ Size | 1 | 2019 | 2249 | 0.030 |
Why?
|
Patient Participation | 1 | 2022 | 1437 | 0.030 |
Why?
|
Midazolam | 1 | 2015 | 267 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2004 | 10829 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 11902 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3568 | 0.030 |
Why?
|
International Cooperation | 1 | 2018 | 1436 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 2013 | 389 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2020 | 58947 | 0.020 |
Why?
|
Models, Neurological | 2 | 2009 | 1758 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2023 | 1843 | 0.020 |
Why?
|
Acute Disease | 1 | 2002 | 7268 | 0.020 |
Why?
|
Stroop Test | 1 | 2010 | 72 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2013 | 8945 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 2101 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2016 | 1548 | 0.020 |
Why?
|
Cricetulus | 1 | 2011 | 815 | 0.020 |
Why?
|
Achievement | 1 | 2010 | 289 | 0.020 |
Why?
|
Verbal Behavior | 1 | 2010 | 335 | 0.020 |
Why?
|
Schizophrenic Language | 1 | 2008 | 57 | 0.020 |
Why?
|
CHO Cells | 1 | 2011 | 1389 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2010 | 568 | 0.020 |
Why?
|
Synapses | 1 | 2017 | 1753 | 0.020 |
Why?
|
Probability | 1 | 2013 | 2476 | 0.020 |
Why?
|
Lod Score | 1 | 2008 | 602 | 0.020 |
Why?
|
Pons | 1 | 2009 | 239 | 0.020 |
Why?
|
Face | 1 | 2013 | 1017 | 0.020 |
Why?
|
Control Groups | 1 | 2007 | 105 | 0.020 |
Why?
|
Cricetinae | 1 | 2011 | 2427 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2015 | 4625 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1617 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9388 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2508 | 0.020 |
Why?
|
Functional Laterality | 1 | 2013 | 2253 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4276 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 2 | 2009 | 4044 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2013 | 2325 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10340 | 0.020 |
Why?
|
Epilepsy | 1 | 2001 | 3267 | 0.020 |
Why?
|
Electroencephalography | 1 | 2020 | 6182 | 0.020 |
Why?
|
Prolactin | 1 | 2006 | 621 | 0.010 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2006 | 263 | 0.010 |
Why?
|
Neurons | 1 | 2023 | 9416 | 0.010 |
Why?
|
Selection, Genetic | 1 | 2008 | 872 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12968 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2008 | 2381 | 0.010 |
Why?
|
Serine | 1 | 2006 | 831 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3466 | 0.010 |
Why?
|
Interview, Psychological | 1 | 2005 | 812 | 0.010 |
Why?
|
Genome, Human | 1 | 2015 | 4416 | 0.010 |
Why?
|
Motor Skills | 1 | 2005 | 520 | 0.010 |
Why?
|
Space Perception | 1 | 2005 | 464 | 0.010 |
Why?
|
Personality Assessment | 1 | 2004 | 650 | 0.010 |
Why?
|
Cysteine | 1 | 2006 | 897 | 0.010 |
Why?
|
Family | 1 | 2012 | 3189 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26168 | 0.010 |
Why?
|
Models, Statistical | 1 | 2014 | 5073 | 0.010 |
Why?
|
Prognosis | 2 | 2012 | 29636 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3774 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2008 | 1428 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 40133 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9336 | 0.010 |
Why?
|
Hippocampus | 1 | 2011 | 3737 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36030 | 0.010 |
Why?
|
Forecasting | 1 | 2007 | 2931 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42034 | 0.010 |
Why?
|
Drug Resistance | 1 | 2004 | 1617 | 0.010 |
Why?
|
Memory | 1 | 2006 | 2179 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 18968 | 0.010 |
Why?
|
Language | 1 | 2005 | 1532 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2696 | 0.010 |
Why?
|
Animals | 3 | 2011 | 167940 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 22025 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2006 | 7803 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 24086 | 0.010 |
Why?
|
Pilot Projects | 1 | 2004 | 8553 | 0.010 |
Why?
|
Mice | 1 | 2011 | 81216 | 0.000 |
Why?
|